Q3 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | Exit | EAGLE PHARMACEUTICALS, INC. | $0 | – | -6,777 | – | -0.79% | – |
Q2 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| URGN | New | UROGEN PHARMA LTD. | $39,275,000 | – | 789,297 | – | 60.44% | – |
| MRSN | New | MERSANA THERAPEUTICS, INC. | $17,069,000 | – | 955,709 | – | 26.27% | – |
| IMDZ | New | IMMUNE DESIGN CORP. | $5,626,000 | – | 1,236,394 | – | 8.66% | – |
| AGRX | New | AGILE THERAPEUTICS, INC. | $2,501,000 | – | 5,062,363 | – | 3.85% | – |
| EGRX | New | EAGLE PHARMACEUTICALS, INC. | $513,000 | – | 6,777 | – | 0.79% | – |
Q4 2017
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | Exit | EAGLE PHARMACEUTICALS, INC. | $0 | – | -6,777 | – | -0.40% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP. | $0 | – | -1,413,280 | – | -14.65% | – |
| MRSN | Exit | MERSANA THERAPEUTICS, INC. | $0 | – | -955,709 | – | -16.55% | – |
| AGRX | Exit | AGILE THERAPEUTICS, INC. | $0 | – | -5,062,363 | – | -22.62% | – |
| URGN | Exit | UROGEN PHARMA LTD. | $0 | – | -1,449,745 | – | -45.77% | – |
Q3 2017
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| URGN | Sell | UROGEN PHARMA LTD. | $45,696,000 | +74.3% | 1,449,745 | -0.1% | 45.77% | +36.6% |
| IMDZ | Sell | IMMUNE DESIGN CORP. | $14,627,000 | -23.6% | 1,413,280 | -28.0% | 14.65% | -40.1% |
| EGRX | Sell | EAGLE PHARMACEUTICALS, INC. | $404,000 | -24.5% | 6,777 | -99.8% | 0.40% | -40.8% |
Q2 2017
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| URGN | New | UROGEN PHARMA LTD. | $26,211,000 | – | 1,451,329 | – | 33.51% | – |
| IMDZ | New | IMMUNE DESIGN CORP. | $19,137,000 | – | 1,962,720 | – | 24.47% | – |
| AGRX | New | AGILE THERAPEUTICS, INC. | $18,984,000 | – | 5,062,363 | – | 24.27% | – |
| MRSN | New | MERSANA THERAPEUTICS, INC. | $13,351,000 | – | 955,709 | – | 17.07% | – |
| EGRX | New | EAGLE PHARMACEUTICALS, INC. | $535,000 | – | 3,652,284 | – | 0.68% | – |
Q4 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC. | $0 | – | -1,900,000 | – | -1.65% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP. | $0 | – | -1,962,720 | – | -4.10% | – |
| AGRX | Exit | AGILE THERAPEUTICS, INC. | $0 | – | -5,062,363 | – | -9.73% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS, INC. | $0 | – | -4,382,764 | – | -84.52% | – |
Q3 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | Sell | EAGLE PHARMACEUTICALS, INC. | $306,793,000 | +65.5% | 4,382,764 | -8.3% | 84.52% | +12.1% |
Q2 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | New | EAGLE PHARMACEUTICALS INC | $185,423,000 | – | 4,780,188 | – | 75.43% | – |
| AGRX | New | AGILE THERAPEUTICS INC | $38,525,000 | – | 5,062,363 | – | 15.67% | – |
| IMDZ | New | IMMUNE DESIGN CORP | $16,016,000 | – | 1,962,720 | – | 6.52% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $5,871,000 | – | 1,900,000 | – | 2.39% | – |
Q4 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSTX | Exit | MAST THERAPEUTICS, INC. | $0 | – | -1,275,925 | – | -0.18% | – |
| ZSAN | Exit | ZOSANO PHARMA CORP. | $0 | – | -229,759 | – | -0.22% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC. | $0 | – | -1,900,000 | – | -2.74% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP. | $0 | – | -1,962,720 | – | -5.67% | – |
| AGRX | Exit | AGILE THERAPEUTICS, INC. | $0 | – | -4,668,663 | – | -7.45% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS, INC. | $0 | – | -4,780,188 | – | -83.76% | – |
Q3 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMDZ | Sell | IMMUNE DESIGN CORP. | $23,945,000 | -41.6% | 1,962,720 | -1.1% | 5.67% | -32.6% |
| MSTX | Sell | MAST THERAPEUTICS, INC. | $740,000 | -40.8% | 1,275,925 | -50.0% | 0.18% | -31.9% |
Q2 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | New | EAGLE PHARMACEUTICALS, INC. | $386,526,000 | – | 4,780,188 | – | 79.39% | – |
| IMDZ | New | IMMUNE DESIGN CORP. | $40,967,000 | – | 1,983,858 | – | 8.41% | – |
| AGRX | New | AGILE THERAPEUTICS, INC. | $40,104,000 | – | 4,668,663 | – | 8.24% | – |
| ANTH | New | ANTHERA PHARMACEUTICALS INC. | $16,378,000 | – | 1,900,000 | – | 3.36% | – |
| ZSAN | New | ZOSANO PHARMA CORP. | $1,666,000 | – | 229,759 | – | 0.34% | – |
| MSTX | New | MAST THERAPEUTICS, INC. | $1,250,000 | – | 2,551,851 | – | 0.26% | – |